Distinct sets of genetic alterations in melanoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  New England Journal of Medicine

• Publication date

  2005-11-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1056/NEJMOA050092PMID 16291983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hidden Markov models approach to the analysis of array CGH data

  2004cited by this paper
• Is there more than one road to melanoma?

  2004cited by this paper
• Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies

  2004cited by this paper
• Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization

  2003cited by this paper
• High frequency of BRAF mutations in nevi

  2003cited by this paper
• Determinants of BRAF mutations in primary melanomas.

  2003cited by this paper
• Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.

  2003cited by this paper
• Shaping of tumor and drug-resistant genomes by instability and selection

  2003cited by this paper
• Classifying melanocytic tumors based on DNA copy number changes.

  2003cited by this paper
• Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Cyclin D1 is a candidate oncogene in cutaneous melanoma.

  2002cited by this paper
• Discovery of a novel Raf kinase inhibitor.

  2001cited by this paper
• Assembly of microarrays for genome-wide measurement of DNA copy number

  2001cited by this paper
• Neonatal sunburn and melanoma in mice

  2001cited by this paper
• Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.

  2000cited by this paper
• Epidemiology of melanoma

  2000cited by this paper
• Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

  2000cited by this paper
• Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

  2000cited by this paper
• p53 expression and risk factors for cutaneous melanoma: A case‐control study

  1998cited by this paper
• Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

  1998cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Role of the INK4a locus in tumor suppression and cell mortality.

  1996cited by this paper
• Predicting five‐year outcome for patients with cutaneous melanoma in a population‐based study

  1996cited by this paper
• Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren.

  1994cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment

  1993cited by this paper
• Cutaneous melanoma: prognosis and treatment results worldwide.

  1992cited by this paper
• Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.

  1989cited by this paper
• Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961-1979.

  1986cited by this paper
• Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland.

  1982cited by this paper
• The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work.

  1981cited by this paper
• LOWESS: A Program for Smoothing Scatterplots by Robust Locally Weighted Regression

  1981cited by this paper
• Malignant melanoma: a unifying concept.

  1980cited by this paper
• The classification of malignant melanoma and its histologic reporting

  1973cited by this paper
• The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

  1969cited by this paper

• Mucosal Melanoma of Head and Neck: A Rare and Aggressive Disease-A Register-Based Cohort Study.

  2026cites this paper
• Genetic Evolution of Melanoma: Comparative Analysis of Candidate Gene Mutations in Healthy Skin, Nevi, and Tumors from the Same Patients

  2026cites this paper
• Melanoma: Pathogenesis and Targeted Therapy

  2026cites this paper
• Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma

  2026influential citation
• Ancestry and somatic profile indicate acral melanoma origin and prognosis

  2026cites this paper
• Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

  2026cites this paper
• Outdoor work as risk factor for facial melanoma: UV exposure, risk awareness, and occupational relevance.

  2026cites this paper
• Sentinel Lymph Node Biopsy in Melanoma: Overview and Updates

  2025cites this paper
• A comprehensive review and case series of adjuvant and neoadjuvant therapies in acral melanoma with emerging insights from CT DNA testing

  2025cites this paper
• c‐KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions

  2025cites this paper
• Development and Evaluation of a Web-Based Outcome Database for Advanced Melanoma with Rare BRAF Mutations

  2025cites this paper
• Current Surgical Management for Acral Melanoma

  2025cites this paper
• The emerging role of dual specificity phosphatase 3 in melanocytic cancer: from oncogenesis to clinical value.

  2025cites this paper
• Targeting oncogenic signal pathway to improve cancer immunotherapy: Insights and perspectives.

  2025cites this paper
• Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening

  2025cites this paper
• Surgical treatment of vaginal and vulvar melanoma: a 18-year retrospective study.

  2025cites this paper
• Acral Melanoma: A Review of Its Pathogenesis, Progression, and Management

  2025cites this paper
• KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy

  2025cites this paper
• Melanoma treatment in the era of nanotechnology and precision medicine

  2025cites this paper
• Clinical integration of germline findings from a tumor testing precision medicine program

  2025cites this paper
• Pannexin 1 crosstalk with the Hippo pathway in malignant melanoma

  2025cites this paper
• Precision medicine in cutaneous melanoma—A comprehensive review

  2025cites this paper
• Novel dibenzoylmethane derivative 2-allyl-1,3-diphenyl-1,3-propanedione: a safe and effective topical treatment for melanoma.

  2025cites this paper
• WHO-Klassifikation melanozytärer Tumoren

  2025cites this paper
• DNA Methylation Array Analysis Identifies Biological Subgroups of Cutaneous Melanoma and Reveals Extensive Differences with Benign Melanocytic Nevi

  2025cites this paper
• An optimised Bcl‐3 inhibitor for melanoma treatment

  2025cites this paper
• Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas

  2025cites this paper
• Cutaneous melanoma

  2025cites this paper
• Combination Immunotherapy for Mucosal Melanoma: Molecular Mechanism, Research Status, and Future Directions

  2025cites this paper
• KS-NailMel-1: a novel cell line of nail apparatus melanoma

  2025cites this paper
• Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanoma

  2025cites this paper
• Association of the BRAFV600E mutation with morphology and heterogeneity in melanoma.

  2025cites this paper
• A multi-omic analysis reveals a predictive value of tertiary lymphoid structures in improving the prognosis of colorectal cancer patients with BRAF mutation

  2025cites this paper
• Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge

  2025cites this paper
• Comprehensive Analysis of BRCA1/2 mutations, "BRCAness" and PARP inhibitors in Melanoma.

  2025cites this paper
• Somatic gene variation profiles in geriatric and adult malignant melanoma patients

  2025cites this paper
• Physical and Chemical Methods for DNA Vaccine Delivery: Insights into the Melanoma Landscape.

  2025cites this paper
• Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy

  2025cites this paper
• Screening and novel diagnostic technologies for melanoma: an update

  2025cites this paper
• Specific oncogene activation of the cell of origin in mucosal melanoma

  2025cites this paper
• Modelling Acral Melanoma in Admixed Brazilians Uncovers Genomic Drivers and Targetable Pathways

  2025cites this paper
• Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Clinical Presentation, and Diagnosis.

  2025cites this paper
• Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20.

  2025cites this paper
• Adjuvant Systemic Immunotherapies for Resected Stage III Melanoma: A Single-Centre Retrospective Clinical Practice Review

  2025cites this paper
• Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

  2025cites this paper
• Fatal Melanoma With MAP4::RAF1 Fusion: Expanding the Clinicopathologic and Prognostic Spectrum of RAF1-Fused Melanomas.

  2025cites this paper
• Penile Skin as a Rare Location of Melanoma in the Balkan Region: A Case Report.

  2025cites this paper
• BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study.

  2025cites this paper
• Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan

  2025cites this paper
• Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma

  2025cites this paper
• Nodular Melanoma.

  2025cites this paper
• Acral Melanoma in Skin of Color: Current Insights and Future Directions: A Narrative Review

  2025cites this paper
• Somatic mutations distinguish melanocyte subpopulations in human skin

  2025cites this paper
• Predicting c-KIT Inhibitor Efficacy in Patient-Derived Models of Sinonasal Mucosal Melanomas through Integrated Histogram Analysis of Whole-Tumor DKI, IVIM, and DCE-MRI.

  2025cites this paper
• NRASQ61K/R/L Mutant Allele Frequency in Melanoma and its Correlation With Clinicopathological Characteristics

  2025cites this paper
• pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy.

  2025cites this paper
• Anatomical distribution of acral lentiginous melanoma in the hand and nail among Japanese individuals.

  2025cites this paper
• Guidelines for diagnosis and pathological report of melanocytic skin lesions ― recommendations from the Brazilian Society of Pathology

  2025cites this paper
• Cell Death Modalities in Therapy of Melanoma

  2025cites this paper
• Stabilization of GTSE1 by cyclin D1–CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis

  2025cites this paper
• Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles

  2025influential citation
• Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma

  2025cites this paper
• Cancer vaccines and the future of immunotherapy.

  2025cites this paper
• Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanoma

  2025cites this paper
• Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter

  2025cites this paper
• Unseen Aggressor: A Case of Amelanotic Melanoma With Orbital Metastasis and Imaging-Pathology Correlation

  2025cites this paper
• Conjunctival melanoma: comprehensive insights into clinical features, genetic alterations, and modern treatment approaches

  2025cites this paper
• A combinatorial chemotherapy approach for prostate and skin cancer cells and its effect on the macrophage immunomodulation

  2025cites this paper
• Targeting Melanoma Cell Adhesion Molecule as a Novel Therapeutic Approach for Acral Melanoma

  2025influential citation
• A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021

  2025cites this paper
• Nested Melanoma and Superficial Spreading Melanoma with Prominent Nests—A Retrospective Study on Clinical Characteristics and PRAME Expression

  2025cites this paper
• Lztr1 deficiency contributes to the pathogenesis of dilated cardiomyopathy via RAP1/PI3K/AKT-mediated myocardial Injury.

  2025cites this paper
• An acylated N-terminus and a conserved loop regulate the activity of the ABHD17 de-acylase

  2024cites this paper
• Specific oncogene activation of the cell of origin in mucosal melanoma

  2024cites this paper
• High prevalence of dermatophytosis of the feet in acral melanoma of the foot

  2024cites this paper
• [[Translated article]]S100-Protein-Negative Mouth Lesion.

  2024cites this paper
• Skin Cancer Precursors: From Cancer Genomics to Early Diagnosis.

  2024cites this paper
• 1265 nm laser irradiation activates antioxidant system in B16-F10 and CHO-K1 cells

  2024cites this paper
• Long‐term follow‐up results from KEYNOTE‐041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma

  2024influential citation
• Melanoma of the dog and cat: consensus and guidelines

  2024cites this paper
• A Review of Contemporary Guidelines and Evidence for Wide Local Excision in Primary Cutaneous Melanoma Management

  2024cites this paper
• Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR

  2024cites this paper
• Risk factors of lentigo maligna as compared to other melanoma subtypes

  2024cites this paper
• De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

  2024cites this paper
• Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database

  2024cites this paper
• Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness

  2024cites this paper
• Recent advancements in the diagnosis and treatment of acral melanoma

  2024influential citation
• Incidental finding of leukaemia in circulating tumour DNA— the importance of a molecular tumour board

  2024cites this paper
• Malignant melanoma located in the ureter and gallbladder: A case report and literature review

  2024cites this paper
• BRAF V600E Mutation in Malignant Melanoma—A Romanian Research Experience

  2024cites this paper
• Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances

  2024cites this paper
• Amplification of mutant NRAS in melanocytic tumors with features of Spitz tumors.

  2024cites this paper
• Integrative Bioinformatics Analysis Reveals Potential Target Genes and PTEN Signaling in Breast Cancer and Effect of Zingiber officinale (Ginger) and Allium sativum (Garlic) extract on It

  2024cites this paper
• Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA

  2024cites this paper
• RhoA activation promotes glucose uptake to elevate proliferation in MAPK inhibitor resistant melanoma cells

  2024cites this paper
• MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study

  2024cites this paper
• Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature

  2024cites this paper
• Exploring STK3 in melanoma: a systematic review of signaling networks and therapeutic opportunities

  2024cites this paper
• Evaluation of Heterogeneity in the Coding Region of BRAF, MAP2K1, and MAP2K2 Genes in Primary and Metastatic Melanomas

  2024cites this paper
• BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia

  2024cites this paper